1
|
Aerts N, Le Goff D, Odorico M, Le Reste JY, Van Bogaert P, Peremans L, Musinguzi G, Van Royen P, Bastiaens H. Systematic review of international clinical guidelines for the promotion of physical activity for the primary prevention of cardiovascular diseases. BMC Fam Pract 2021; 22:97. [PMID: 34011279 PMCID: PMC8136198 DOI: 10.1186/s12875-021-01409-9] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/23/2020] [Accepted: 03/09/2021] [Indexed: 12/03/2022]
Abstract
BACKGROUND Cardiovascular diseases are the world's leading cause of morbidity and mortality. An active lifestyle is one of the cornerstones in the primary prevention of cardiovascular disease. An initial step in guiding primary prevention programs is to refer to clinical guidelines. We aimed to systematically review clinical practice guidelines on primary prevention of cardiovascular disease and their recommendations regarding physical activity. METHODS We systematically searched Trip Medical Database, PubMed and Guidelines International Network from January 2012 up to December 2020 using the following search strings: 'cardiovascular disease', 'prevention', combined with specific cardiovascular disease risk factors. The identified records were screened for relevance and content. We methodologically assessed the selected guidelines using the AGREE II tool. Recommendations were summarized using a consensus-developed extraction form. RESULTS After screening, 27 clinical practice guidelines were included, all of which were developed in Western countries and showed consistent rigor of development. Guidelines were consistent about the benefit of regular, moderate-intensity, aerobic physical activity. However, recommendations on strategies to achieve and sustain behavior change varied. Multicomponent interventions, comprising education, counseling and self-management support, are recommended to be delivered by various providers in primary health care or community settings. Guidelines advise to embed patient-centered care and behavioral change techniques in prevention programs. CONCLUSIONS Current clinical practice guidelines recommend similar PA lifestyle advice and propose various delivery models to be considered in the design of such interventions. Guidelines identify a gap in evidence on the implementation of these recommendations into practice.
Collapse
Affiliation(s)
- N. Aerts
- Department of Primary and Interdisciplinary Care, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
| | - D. Le Goff
- Department of General Medicine, SPURBO, Université de Bretagne Occidentale, University of West Brittany, 7479 Brest, EA France
| | - M. Odorico
- Department of General Medicine, SPURBO, Université de Bretagne Occidentale, University of West Brittany, 7479 Brest, EA France
| | - J. Y. Le Reste
- Department of General Medicine, SPURBO, Université de Bretagne Occidentale, University of West Brittany, 7479 Brest, EA France
| | - P. Van Bogaert
- Department of Nursing and Midwifery, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerpen, Belgium
| | - L. Peremans
- Department of Primary and Interdisciplinary Care, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
- Department of Nursing and Midwifery, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerpen, Belgium
| | - G. Musinguzi
- Department of Primary and Interdisciplinary Care, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
- Department of Disease Control and Environmental Health, School of Public Health, College of Health Sciences, Makerere University, Kampala, Uganda
| | - P. Van Royen
- Department of Primary and Interdisciplinary Care, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
| | - H. Bastiaens
- Department of Primary and Interdisciplinary Care, Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium
| |
Collapse
|
3
|
Pisani C, Gaillard J, Odorico M, Nyalosaso J, Charnay C, Guari Y, Chopineau J, Devoisselle J, Armengaud J, Prat O. Corona interactome: A key for deciphering protein adsorption kinetics on silica nanocarriers surface. Toxicol Lett 2016. [DOI: 10.1016/j.toxlet.2016.06.1980] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
4
|
Le Reste JY, Nabbe P, Lingner H, Kasuba Lazic D, Assenova R, Munoz M, Sowinska A, Lygidakis C, Doerr C, Czachowski S, Argyriadou S, Valderas J, Le Floch B, Deriennic J, Jan T, Melot E, Barraine P, Odorico M, Lietard C, Van Royen P, Van Marwijk H. What research agenda could be generated from the European General Practice Research Network concept of Multimorbidity in Family Practice? BMC Fam Pract 2015; 16:125. [PMID: 26381383 PMCID: PMC4574005 DOI: 10.1186/s12875-015-0337-3] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 05/09/2015] [Accepted: 09/07/2015] [Indexed: 01/08/2023]
Abstract
Background Multimorbidity is an intuitively appealing, yet challenging, concept for Family Medicine (FM). An EGPRN working group has published a comprehensive definition of the concept based on a systematic review of the literature which is closely linked to patient complexity and to the biopsychosocial model. This concept was identified by European Family Physicians (FPs) throughout Europe using 13 qualitative surveys. To further our understanding of the issues around multimorbidity, we needed to do innovative research to clarify this concept. The research question for this survey was: what research agenda could be generated for Family Medicine from the EGPRN concept of Multimorbidity? Methods Nominal group design with a purposive panel of experts in the field of multimorbidity. The nominal group worked through four phases: ideas generation phase, ideas recording phase, evaluation and analysis phase and a prioritization phase. Results Fifteen international experts participated. A research agenda was established, featuring 6 topics and 11 themes with their corresponding study designs. The highest priorities were given to the following topics: measuring multimorbidity and the impact of multimorbidity. In addition the experts stressed that the concept should be simplified. This would be best achieved by working in reverse: starting with the outcomes and working back to find the useful variables within the concept. Conclusion The highest priority for future research on multimorbidity should be given to measuring multimorbidity and to simplifying the EGPRN model, using a pragmatic approach to determine the useful variables within the concept from its outcomes.
Collapse
Affiliation(s)
- J Y Le Reste
- ERCR SPURBO, Department of General Practice, Université de Bretagne Occidentale, Brest, France.
| | - P Nabbe
- ERCR SPURBO, Department of General Practice, Université de Bretagne Occidentale, Brest, France.
| | - H Lingner
- Centre for Public Health and Healthcare, Hannover Medical School, Hannover, Germany.
| | - D Kasuba Lazic
- Department of General Practice, University of Zagreb, Zagreb, Croatia.
| | - R Assenova
- Department of General Practice, University of Plovdiv, Plovdiv, Bulgaria.
| | - M Munoz
- IDIAP Jordi GOL Unitat de Support a la Recerca, Barcelona, Spain.
| | - A Sowinska
- Department of English, Nicolaus Copernicus University, Torun, Poland.
| | - C Lygidakis
- Associazione Italiana Medici di Famiglia (AIMEF), Bologna, Italy.
| | - C Doerr
- Allgemein Medizin Hochschule Göttingen, Göttingen, Germany.
| | - S Czachowski
- Department of Family Doctor, University Nicolaus Copernicus, Torun, Poland.
| | - S Argyriadou
- The Greek Association of General Practitioners (ELEGEIA), Thessaloniki, Greece.
| | - J Valderas
- Patient Centred Care Lead, University of Exeter Collaboration for Academic Primary Care (APEx), University of Exeter Medical School, Exeter, UK.
| | - B Le Floch
- ERCR SPURBO, Department of General Practice, Université de Bretagne Occidentale, Brest, France.
| | - J Deriennic
- ERCR SPURBO, Department of General Practice, Université de Bretagne Occidentale, Brest, France.
| | - T Jan
- ERCR SPURBO, Department of General Practice, Université de Bretagne Occidentale, Brest, France.
| | - E Melot
- ERCR SPURBO, Department of General Practice, Université de Bretagne Occidentale, Brest, France.
| | - P Barraine
- ERCR SPURBO, Department of General Practice, Université de Bretagne Occidentale, Brest, France.
| | - M Odorico
- ERCR SPURBO, Department of General Practice, Université de Bretagne Occidentale, Brest, France.
| | - C Lietard
- Department of Public Health, Université de Bretagne Occidentale, Brest, France.
| | - P Van Royen
- Department of Primary and Interdisciplinary Care, Faculty of Medicine and Health Sciences, Universiteit Antwerpen, Antwerpen, Belgium.
| | - H Van Marwijk
- Primary Care Research Center, Williamson Building, Oxford Road, Manchester, UK.
| |
Collapse
|
5
|
Bertoli R, Bissig M, Caronzolo D, Odorico M, Pons M, Bernasconi E. Assessment of potential drug-drug interactions at hospital discharge. Swiss Med Wkly 2010; 140:w13043. [PMID: 20373176 DOI: 10.4414/smw.2010.13043] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
OBJECTIVE The evaluation of the prevalence of potential drug-drug interactions and assessment of their clinical relevance in patients' discharge medication in the medical ward of a community teaching hospital. The relevant clinical information was reported to the treating physicians. METHODS 200 patients at discharge from a medical ward were included. Prescribed drugs were analysed for interactions using commercially available software (Pharmavista). Clinical pharmacists and a physician assessed the clinical relevance of detected interactions, eliminated those which were not considered clinically relevant and formulated recommendations for those considered clinically relevant. A written recommendation was given to the physician to provide rapid feedback before discharge. RESULTS The median age of the 200 patients studied was 69 years. At discharge, patients took an average of 7 different drugs. 62.5% of patients had at least one potential drug-drug interaction. In total, 373 potential drug-drug interactions were identified: 223 (60%) of minor severity, 143 (38%) of moderate severity and 7 (2%) of major severity. CONCLUSIONS A computerised drug-drug interaction program (detection) together with clinical pharmacological experience (interpretation/evaluation) can be useful for decreasing the number of potentially harmful drug combinations. This approach may lead to an improvement in the quality of prescription, reducing possible risks and thus contributing to patient safety.
Collapse
Affiliation(s)
- Raffaela Bertoli
- Servizio di consulenza sui farmaci e Centro Regionale di Farmacovigilanza, Ospedale Regionale di Lugano, Lugano, Lugano, Switzerland.
| | | | | | | | | | | |
Collapse
|
6
|
Odorico M, Teulon JM, Berthoumieu O, Chen SWW, Parot P, Pellequer JL. An integrated methodology for data processing in dynamic force spectroscopy of ligand–receptor binding. Ultramicroscopy 2007; 107:887-94. [PMID: 17644254 DOI: 10.1016/j.ultramic.2007.04.019] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
Dynamic force spectroscopy (DFS), using atomic force microscopy (AFM), is a powerful tool to study ligand-receptor binding. The interaction mode of two binding partners is investigated by exploring stochastic behaviors of bond rupture events. However, to define a rupture event from force-distance measurements is not conclusive or unique in literature. To reveal the influence of event identification methods, we have developed an efficient protocol to manage tremendous amount of data by implementing different choices of peak selection from the force-distance curve. This data processing software simplifies routinely experimental procedures such as cantilever spring constant and force-distance curve calibrations, statistical treatments of data, and analysis distributions of rupture events. In the present work, we took available experimental data from a complex between a chelate metal compound and a monoclonal antibody as a study system.
Collapse
Affiliation(s)
- M Odorico
- CEA-Valrho, DSV-DIEP-SBTN, BP 17171, Bagnols sur Cèze 30207, France
| | | | | | | | | | | |
Collapse
|